Evidence Hub

Combined Nebulized and IV Tranexamic Acid for Hemoptysis Management: A Case Report and Brief Literature Review

E. Ghadirzadeh, Faezeh Shokri, Shamim Khorshidian, Anita Ziari, Mobina Gheibi, Majidreza Adelani, Seyed Pooria Salehi Mashhad Sari, Fatemeh Varshoei et al.

Clinical Case Reports, 2025

1 citation

Abstract

Hemoptysis management may necessitate invasive interventions, but combined nebulized and intravenous tranexamic acid (TXA) can play a promising noninvasive role in controlling hemoptysis. This case report describes two patients with non‐life‐threatening hemoptysis (a 71‐ and a 69‐year‐old man) successfully treated with combined nebulized and systemic IV TXA. A 71‐year‐old man with COPD exacerbation and non‐life‐threatening hemoptysis was successfully treated with TXA (both IV and nebulized) and standard care, which controlled the bleeding without adverse events or recurrence, and was discharged after 7 days. A 69‐year‐old male with bronchiectasis exacerbation experienced non‐life‐threatening hemoptysis. He was successfully treated with IV and nebulized TXA along with standard care, resolving the hemoptysis without recurrence and discharging the patient 8 days after admission. Existing evidence supports nebulized TXA's localized action, minimizing systemic absorption and thrombotic risks, though its efficacy on hemoptysis remains unproven. A brief review of 30 cases highlights nebulized TXA's high success rate with doses ranging from 250 to 2000 mg, though rare side effects like bronchospasm and serotonin‐like syndrome warrant caution. Playing a role as a potential alternative approach for antifibrinolytic administration in hemoptysis, especially for high‐thrombotic‐risk patients, and serving as a vital stabilization and bridging strategy before definitive interventional…

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free